Total Brain Ltd (ttb) Logo

Total Brain Ltd (TTB)

___:___ · AUD
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

TTB Chart

TTB's Principal Activity is the developing and selling brain health products.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2021 YTD
1 Year
vs Sector (1yr) -18.96%
vs ASX 200 (1yr) -32.44%

Size

Market Capitalisation
ASX Rank 1,535 of 2,295
Sector Rank 138 of 177

Key Information

Shares Issued
Sector Healthcare
Similar Companies LBT / PAA / EMD
EPS $0.358
DPS $0.00
NTA per share $0.04

Broker Consensus

TTB is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Date Heading Pages File Size Time

Company Overview

Total Brain Limited (TTB, formerly Brain Resource Limited) is developing and selling brain health products to consumers, corporates, clinicians and research. Its SaaS platform has helped more than 960,000 registered users to-date scientifically measure and optimise their brain capacities while managing the risk of common mental conditions.

Incorporation Details

Incorporated in NSW on 08/08/2000. Name changed to Brain Resource Limited on 07/05/2008.

Corporate Details

Head Office Surry Hills NSW 2010
Website www.totalbrain.com
Registry BoardRoom
Auditor Grant Thornton Audit Pty Ltd
Date Listed 28 Aug 2001

Upcoming Calendar (Forecasted)

Date Event
27/08/2021 Report (Prelim)
27/08/2021 Report (Annual)
24/02/2022 Report (Interim)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Mr David Daglio Non-Executive Director Jan 2020 Director Bio icon

Mr David Daglio

Non-Executive Director

Mr Daglio has a career spanning 21 years with Mellon, a U.S. Asset Manager where David most recently served as Executive Vice President and Chief Investment Officer. He remains a Non-Executive Director of Mellon. David helped and manage the merger of three companies to create Mellon. In his role as a Portfolio Manager and Chief Investment Officer, David and his team were winners of numerous awards for fund performance. He is Member of remuneration Committee.

Mr Nathan Jong Joint Company Secretary Nov 2019
Mr David Torrible Non-Executive Director Jun 2019 Director Bio icon

Mr David Torrible

Non-Executive Director

Mr Torrible is non-executive director and advisor to private companies, financial firms and charities since 2012 when he retired as a partner of Goldman Sachs. Prior to 2012 he worked 19 years as an equity specialist serving institutional accounts in Asian capital markets. He has worked in Hong Kong, Indonesia, USA and Australia. He is experienced in relationship management, capital market risk and managing geographically diverse teams. He is Chairman of the Nomination and Remuneration Committee and member of the Audit and Risk Committee.

Mr Phillip Hains Joint Company Secretary Jul 2018
Mr Louis Gagnon Chief Executive Officer,Managing Director May 2017 Director Bio icon

Mr Louis Gagnon

Chief Executive Officer,Managing Director

Mr Gagnon has been the Chief Executive Officer (CEO) of the Company since 23 May 2017. Louis has over 25 years of experience as a high-growth global digital business leader where he served as Chief Product and Marketing Officer. Prior to working with the Company, Louis was an Advisor to TPG Capital following a short CEO assignment to turn around portfolio company Ride.com. His other past roles include Chief Product and Marketing Officer at Yodle and Senior VP of Global Products at Monster Worldwide.

Mr Matthew (Matt) Morgan Non-Executive Director Mar 2016 Director Bio icon

Mr Matthew (Matt) Morgan

Non-Executive Director

Mr Morgan is a former venture capitalist who is the Principal of Millers Point Company, an advisory firm focused on emerging growth companies. He was a co-founder of Diversa Ltd which was sold to OneVue. He is chairman Chairman of the Audit and Risk Committee and member of the Nomination and Remuneration Committee

Dr Evian Gordon Executive Chairman,Executive Director Aug 2000 Director Bio icon

Dr Evian Gordon

Executive Chairman,Executive Director

Dr Gordon has over 30 years of experience in human brain research. He was the director of the Brain Dynamics Centre at Westmead Hospital and a senior lecturer in the Department of Psychological Medicine at the University of Sydney. Dr Gordon edited the book "Integrative Neuroscience" and has more than 200 publications credited to him.

Director Transactions

TTB directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
06/08/20 Evian Gordon Issued 1,205,156 $0.435 $524,242 Issue of securities
06/08/20 Louis Gagnon Sell +2,823,297 $0.435 ($1,228,134) As advised by the company
06/08/20 Louis Gagnon Issued 5,423,297 $0.435 $2,359,134 Issue of securities
16/01/20 David Torrible Issued 29,126,903 $0.046 $1,339,838 Issue of securities
16/01/20 David Torrible Issued 2,066,115 $0.83 $1,714,875 Issue of options
16/01/20 David Torrible Issued 2,066,115 $0.83 $1,714,875 Issue of options
16/01/20 David Torrible Issued 29,126,903 $0.046 $1,339,837 Issue of securities
15/01/20 Evian Gordon Transfer 1,778,500 $0.70 $1,244,950 Off-market transfer
15/01/20 Evian Gordon Transfer 1,778,500 $0.70 $1,244,950 Off-market transfer
15/01/20 Evian Gordon Transfer 1,778,500 $0.70 $1,244,950 Off-market transfer
15/01/20 Evian Gordon Transfer 1,778,500 $0.70 $1,244,950 Off-market transfer
22/11/19 Ajay Arora Issued 1,920,810 $0.105 $201,685 Issue of options
16/05/19 Matthew (Matt) Morgan Buy +296,429 $0.028 $8,300 Off-market trade
12/02/19 Matthew (Matt) Morgan Buy +315,111 $0.027 $8,558 On-market trade
19/12/18 Matthew (Matt) Morgan Buy +284,320 $0.03 $8,530 On-market trade
16/11/18 Matthew (Matt) Morgan Buy +134,219 $0.035 $4,698 On-market trade

Director Interests

The current holdings of TTB directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Louis Gagnon 06/08/2020 415,923 N/A 8,746,593 N/A
Evian Gordon 06/08/2020 1,301,875 N/A 1,205,156 N/A
David Daglio 30/06/2020 6,950,181 N/A N/A N/A
David Torrible 30/06/2020 N/A 60,552,649 206,612 N/A
Matthew (Matt) Morgan 30/06/2020 N/A 4,447,231 425,000 N/A

Shareholder Info

Top 20 Shareholders About the Data

Data supplied by Morningstar and accurate on Aug 3, 2020.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Citicorp Nominees Pty Limited 32,181,835 29.71%
Cs Third Nominees Pty Limited 10,507,673 9.70%
Hsbc Custody Nominees (Australia) Limited 6,224,416 5.75%
HSBC Custody Nominees 5,855,282 5.41%
Stuttgart Pty Ltd 3,900,001 3.60%
BNP Paribas Nominees Pty Ltd 2,886,631 2.67%
Morgan Stanley Australia Securities (Nominee) Pty Limited 2,723,340 2.51%
Invia Custodian Pty Limited 2,557,312 2.36%
Mr Garrett Walker 2,040,154 1.88%
Hsbc Custody Nominees (Australia) Limited I 1,875,337 1.73%
J P Morgan Nominees Australia Pty Limited 1,862,196 1.72%
Dr Evian Gordon 1,124,025 1.04%
Dbpc Group Finance Pty Ltd 1,025,000 0.95%
Gleneagle Securities (Aust) Pty Ltd 993,687 0.92%
C & K Bothwell Pty Ltd 908,888 0.84%
Ceyx Holdings Pty Ltd 900,000 0.83%
Coleman Fung 715,441 0.66%
Mr Tim Yates 715,441 0.66%
Mr David John Acton & Mrs Brooke Elizabeth Acton 620,000 0.57%
Mrs Diane Colman 600,000 0.55%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 150 276 142 302 106 976

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Name Last Notice Total Shares Shares Held (%)
Citicorp Nominees Pty Limited 03/08/2020 32,181,835 29.71
HSBC Custody Nominees (Australia) Limited 03/08/2020 6,224,416 5.75
HSBC Custody Nominees 03/08/2020 5,855,282 5.41
CS Third Nominees Pty Ltd 03/08/2020 10,507,673 9.70

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2020 $0.375 30 June
2019 $0.026 28 June
Page Icon
TTB Historical Price Data (CSV)
Up to 20 years of EOD share price history
Lock Icon
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.